Prescription Drugs - Research and Data from KFF

March 30, 2006 Policy Forum to Release the National ADAP Monitoring Report

Event Date: Mar 2, 2006

Event

The National ADAP Monitoring Report provides the latest data on state AIDS Drug Assistance Programs (ADAPs). ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS. ADAPs operate in 57 U.S. states, territories, and associated jurisdictions. The report, the tenth in an annual series, was prepared by the Kaiser Family Foundation and the National Alliance of State and…

Medicare Part D 2008 Data Spotlight: Utilization Management

Jan 2, 2008

Issue Brief

This Medicare Part D data spotlight examines three common techniques used by Medicare stand-alone prescription drug plans in 2008 to manage enrollees’ use of formulary drugs, such as quantity limits, prior authorization, and step therapy rules. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices. It analyzes data from the 47 stand-alone prescription drug plans available nationwide using a sample of 169 commonly-used and high-cost…

Medicare Part D 2010 Data Spotlight: A Comparison of PDPs Offering Basic and Enhanced Benefits

Nov 30, 2009

Report

This Part D Data Spotlight examines key differences between basic and enhanced Medicare stand-alone prescription drug plans (PDPs), including monthly premiums, cost sharing, and gap coverage. It also examines plan names to assess whether they convey meaningful differences between basic and enhanced PDPs. Companies that sponsor Medicare Part D prescription drug plans are required to offer a basic benefit, either the standard Part D benefit defined by law or an actuarially equivalent benefit design. Plan…

2017 Employer Health Benefits Survey

Sep 19, 2017

Report

Excerpt: This annual Employer Health Benefits Survey (EHBS) provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, and other relevant information. The 2017 survey finds average family health premiums rose 3 percent, the sixth straight year of relatively modest growth, to reach 18,764 annually on average.

Poll: On Health Care, Democrats and Democratic-Leaning Independents Trust Sen. Sanders the Most, but Significantly More People Support a Public Option than Medicare-for-All

Nov 20, 2019

News Release

3 in 4 Americans Do Not Expect Congress to Take Action to Lower Drug Costs Before the 2020 Election Ahead of tonight’s Democratic presidential debate, Sen. Bernie Sanders is the candidate most trusted on health care by Democrats and Democratic-leaning independents, though the Medicare-for-all plan he has championed is significantly less popular than the “public option” approach put forward by some other candidates, the latest KFF Health Tracking Poll finds. Among the overall public, a…

Quick Look: Antiretroviral Price Increases in Medicare Part D

Dec 17, 2019

Issue Brief

Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the federal government if prices increase faster than inflation. We assessed list price changes for ARVs under Part D, which is required to cover all or substantially all ARVs.

Most Antiretrovirals Covered by Medicare Part D (as of 2017) Are Brand-Name, Single Source Medications

Dec 18, 2019

Feature

Most ARVs Covered by Medicare Part D are Brand Single Source Download

Almost Three-Quarters of Antiretrovirals Covered by Medicare Part D Had List Price Increases Above Inflation Between 2016 and 2017

Dec 18, 2019

Feature

Three-quarters of Part D ARVs Had Price Increases Above Inflation Download

Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price Increases Exceeding Inflation

Dec 18, 2019

Feature

All 10 Part D ARVs w Highest Spending Had Price Increases Above Inflation Download

Among the Most Commonly Used Antiretrovirals Covered by Part D in 2017, 9 of 10 Had List Prices Exceeding Inflation

Dec 18, 2019

Feature

9 of 10 Most Commonly Used ARVs in Part D Had List Prices Above Inflation Download

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Prescription Drugs

Filter